HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Primary splenic lymphoma associated with hemophagocytic lymphohistiocytosis complicated with splenic rupture.

Abstract
Primary splenic lymphoma (PSL) is a rare disease with ambiguous definition, comprising less than 1% of non-Hodgkin's lymphoma. Even rarer is PSL combined with hemophagocytic lymphohistiocytosis (HLH), which has presentations of fever, cytopenia, hepatosplenomegaly, hyperferritinemia, and phagocytosis of hematopoietic cells in the reticuloendothelial system. We report the case of a 77-year-old man who presented with HLH initially. Refusing diagnostic splenectomy, he received chemotherapy. Spontaneous splenic rupture occurred after chemotherapy. In the following emergency operation, PSL was diagnosed. He received another 5 courses of chemotherapy with the R-CNOP regimen (rituximab, cyclophosphamide, mitoxantrone, vincristine, prednisolone). Now he has no residual or relapsed disease. Diagnostic splenectomy for adult HLH patients without definite etiologies may play an important role.
AuthorsShao-Min Han, Chieh-Lin Teng, Guang-Yuh Hwang, Guan Chou, Che-An Tsai
JournalJournal of the Chinese Medical Association : JCMA (J Chin Med Assoc) Vol. 71 Issue 4 Pg. 210-3 (Apr 2008) ISSN: 1726-4901 [Print] Netherlands
PMID18436505 (Publication Type: Case Reports, Journal Article)
Topics
  • Aged
  • Humans
  • Lymphohistiocytosis, Hemophagocytic (complications)
  • Lymphoma, Large B-Cell, Diffuse (complications, therapy)
  • Male
  • Splenic Neoplasms (complications, therapy)
  • Splenic Rupture (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: